睿智医药最新股东户数环比下降5.99% 筹码趋向集中

Core Points - The company reported a decrease in the number of shareholders, with a total of 44,659 shareholders as of September 20, down by 2,847 from the previous period, representing a decline of 5.99% [2] - The closing price of the company's stock was 11.99 yuan, reflecting a slight increase of 0.33%, but the stock has cumulatively decreased by 9.17% since the concentration of shares began, with 3 days of increase and 7 days of decrease [2] - The latest margin trading data shows a total margin balance of 236 million yuan as of September 23, with a reduction of 53.15 million yuan, indicating a decline of 18.37% since the concentration of shares began [2] - The company's semi-annual report indicated a revenue of 534 million yuan for the first half of the year, representing a year-on-year growth of 14.75%, and a net profit of 25.38 million yuan, which is a significant increase of 140.35% year-on-year, with basic earnings per share at 0.0510 yuan and a weighted average return on equity of 2.07% [2]